Manifestaciones neurooftalmológicas del síndrome de POEMS

Huang, 2019, Endocrine manifestations in POEMS syndrome: A case report and literature review, BMC Endocr Disord., 19, 33, 10.1186/s12902-019-0355-6 Ziff, 2019, Frequent central nervous system, pachymenungeal and plexus MRI changes in POEMS syndrome, J Neurol., 266, 1067, 10.1007/s00415-019-09233-z Cerri, 2019, An update on the diagnosis and management of polyneuropathy of POEMS syndrome, J Neurol., 266, 258, 10.1007/s00415-018-9068-4 Ortiz, 2018, Neuro-ophthalmological findings in TAFRO syndrome in a patient from South America, a variant of multicentric Castleman's disease, Int Ophthalmol, 38, 1641, 10.1007/s10792-017-0636-x Suichi, 2019, Proposal of new clinical diagnostic criteria for POEMS syndrome, J Neurol Neurosurg Psychiatry., 90, 133, 10.1136/jnnp-2018-318514 Barnés, 2008, Papilledema as an indicator of POEMS syndrome, Arch Soc Esp Oftalmol., 83, 709, 10.4321/S0365-66912008001200005 Zhang, 2017, Ocular manifestations and treatment outcomes in Chinese patients with POEMS Syndrome, Retina., 37, 1784, 10.1097/IAE.0000000000001409 Yokouchi, 2017, Changes in subfoveal choroidal thickness and reduction of serum levels of vascular endothelial growth factor in patients with POEMS syndrome, Br J Ophthalmol., 101, 786, 10.1136/bjophthalmol-2016-309319 Jindahra, 2018, Atypical central retinal artery occlusion as the first presentation of POEMS syndrome: A case report, BMC Neurol., 18, 64, 10.1186/s12883-018-1071-y Kourelis, 2016, Long-term outcome of patients with POEMS syndrome: An update of the Mayo Clinic experience, Am J Hematol., 91, 585, 10.1002/ajh.24356